Stock detail
ImmunityBio (IBRX) stock price, chart, and key data
View ImmunityBio stock price, chart movement, and headline metrics on Woodstock's stock detail page.
Stock detail
ImmunityBio
IBRX · XNAS
$8.22
+6.48%
+$0.50
Key metrics
52-week range
$1.00 - $3.00
Close price
$7.72
Market cap
$8.5B
P/E ratio
-35.07
Beta
1.33
About the company
ImmunityBio Inc. Common Stock
ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.
Analyst rating summary
A current read on analyst sentiment from the insight feed.
Mean target
$13.00
3
Buy
/ 3
Recent calls
09/08/2026
Piper Sandler
Edward Tenthoff
Buy · Price target $12.00
08/04/2026
BTIG
Jeet Mukherjee
Buy · Price target $12.00
08/04/2026
H.C. Wainwright
Andres Y. Maldonado
Buy · Price target $15.00
Ticker holders
Review politician disclosures and insider transactions in tabs.
Holder directory
Select a heading to reorder by name, activity date, buy/sell, or displayed value.
#1Dan Goldman democrat · House · NY-10 self |
| $1,001/$8,001/$15,000 |
24/5 Trading
Act on the stock when the timing works for you.
With Woodstock, you can move from chart review to order placement in one flow. Trade eligible US stocks 24/5, even outside regular market hours.
*24-hour trading is available except during system maintenance. Some stocks are not eligible for extended-hours trading.
Download the app